NCT06349564NARecruitingAccepts Healthy Volunteers
Implementing Virtual Reality (VR) to Reduce Sedation
NYU Langone Health
Start Date
12/9/2024
Completion Date
9/1/2026
Summary
The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose of this study is to assess the feasibility, effect, and safety of using VR goggles during endoscopic procedures to decrease sedation requirements, enhance patient satisfaction, and reduce recovery time.
Eligibility Criteria
Age Range: 21 years to 65 years
INTERVENTION GROUP
Inclusion Criteria:
* Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
* Aged 21 to 65
Exclusion Criteria:
* Visual impairments such as blindness which would impair them from watching the entertainment videos.
* Patients with history of CAD,
* History of seizures,
* History of vertigo,
* History of allergy to plastic,
* ASAII or III,
* Patient with active GI bleed, having either melena or hematochezia.
CONTROL GROUP
Inclusion Criteria:
* Underwent screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
* Aged 21 to 65
Exclusion Criteria:
* Visual impairments such as blindness which would impair them from watching the entertainment videos
* Patients with history of CAD
* History of seizures
* History of vertigo
* History of allergy to plastic
* ASAII or III
* Patient with active GI bleed, having either melena or hematochezia
Interventions
DEVICE
Pico 4 Enterprise headset with noise cancelling headphones
Conditions
Sedative During Endoscopy
Locations
NYU Langone Brooklyn
Brooklyn, New York 11220
United States